Crisp, an Amsterdam, The Netherlands-based provider of a supermarket app focused on building a fresh and transparently sourced product assortment, raised €30m in Series B financing.
Ellipsis Drive, an Ede, The Netherlands-based provider of a plug and play solution for using, sharing, and selling spatial data, raised $2.3m in seed funding.
Mosa Meat, a Maasticht, the Netherlands-based food technology company that offers a cultivated beef hamburger, held a $10m third and last closing of its Series B funding.
Ageras Group, a global B2B accounting technology company, raised €60M in funding.
Veylinx, an Amsterdam, The Netherlands-based behavioral insights platform that uses skin-in-the-game to predict consumer purchase behavior, raised $2m in pre-Series A funding.
VectorY, an Amsterdam, The Netherlands-based fully integrated gene therapy company focused on the development of innovative vectorized antibodies for muscular and neurodegenerative disorders, has officially launched.
InteRNA Technologies, an Utrecht, The Netherlands-based company that designs new therapies tackling cancer, closed an extended Series B financing round amounting to €18.5M in total.
HousingAnywhere, a Rotterdam, The Netherlands-based rental accommodation marketplace for young professionals and international students, raised €24m in Series C funding.
Proto Labs, Inc. (NYSE: PRLB) completed the acquisition of 3D Hubs, Inc., an Amsterdam, The Netherlands-based online manufacturing platform that provides customers with on-demand access to a global network of approximately 240 premium manufacturing partners.
Proto Labs, Inc. (NYSE: PRLB), a Maple Plain, Minn.-based global technology-enabled digital manufacturing company, is to acquire 3D Hubs, Inc., an Amsterdam, The Netherlands-based online manufacturing platform that provides engineers with on-demand access to a global network of approximately 240 premium manufacturing partners.
Kambr, an Utrecht, The Netherlands-based travel-tech startup, raised $3m in additional seed funding.
NewAmsterdam Pharma (NAP), a Naarden, the Netherlands-based clinical stage company focused on the research and development of transformative therapies for cardio-metabolic diseases, closed a $196M (€160M) Series A funding round.
Spryker, a Berlin, Hamburg, Germany- and Amsterdan, The Netherlands-based provider of a commerce technology platform for global enterprises, raised over $130m in Series C financing round.
Phenom, a Philadelphia, PA-based HR technology company, acquired Endouble, an Amsterdam, The Netherlands–based company providing a platform to enhance the candidate experience across Europe.